DPI-221

DPI-221
(IUPAC) ime
4-((αS)-α-((2S,5R)-2,5-dimetil-4-(3-fluorobenzil)-1-piperazinil)benzil)-N,N-dietilbenzamid
Klinički podaci
Identifikatori
ATC kod ?
PubChem[1][2] 9891642
Hemijski podaci
Formula C21H38FN3O 
Mol. masa 487,65 g/mol
SMILES eMolekuli & PubHem
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

DPI-221 je lek koji se koristi u naučnim istraživanjima. On je visoko selektivni agonist δ-opioidnog receptora, koji proizvodi konvulzije u manjoj meri nego drugi lekovi iz ove familije.[3]

Literatura

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Holt, JD; Watson, MJ; Chang, JP; O'Neill, SJ; Wei, K; Pendergast, W; Gengo, PJ; Chang, KJ (2005). „DPI-221 4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats”. The Journal of pharmacology and experimental therapeutics 315 (2): 601–8. DOI:10.1124/jpet.105.090498. PMID 16020629. 

Spoljašnje veze

[uredi | uredi kod]